Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Long-Term Deferred Tax (2017 - 2018)

Lisata Therapeutics' Long-Term Deferred Tax history spans 4 years, with the latest figure at $575055.0 for Q1 2018.

  • For Q1 2018, Long-Term Deferred Tax changed N/A year-over-year to $575055.0; the TTM value through Mar 2018 reached $575055.0, changed N/A, while the annual FY2017 figure was $575000.0, N/A changed from the prior year.
  • Long-Term Deferred Tax reached $575055.0 in Q1 2018 per LSTA's latest filing, roughly flat from $575000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $575055.0 in Q1 2018 to a low of $575000.0 in Q4 2017.